Indian Cabazitaxel Exporters: Complete Supplier Ranking with Market Share — 107 Manufacturers (2026) — TransData Nexus

Q: Who is the largest cabazitaxel buyer importing from India?

ACCORD HEALTHCARE POLSKA SP. Z.O.O. (POLAND) is the largest cabazitaxel importer from India with a 6.2% market share and import value of $573.9K.

Q: How many cabazitaxel buyers import from India?

There are 107 active cabazitaxel buyers importing from India, with a combined import market of $9.2M across 307 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top cabazitaxel buyers from India?

The top 5 cabazitaxel buyers — ACCORD HEALTHCARE POLSKA SP. Z.O.O., ACCORD HEALTHCARE ITALIA SRL., MSN LABS CHILE SPA, ALLOGA FRANCE, ACCORD HEALTHCARE, SLU — together control 23.9% of total cabazitaxel import value from India.

Suresh Sormare

Cabazitaxel

India Pharmaceutical Trade Intelligence

$9.2M59 Suppliers49 CountriesHS 30049049

ExportsIndia → RUSSIA25.7%India → ITALY14.8%

ImportsCANADA → India$304.7K UNITED STATES → India$105.3K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: ACCORD HEALTHCARE

Market Analysis: Top Importing Countries & Their Importers

1Russia

Russia emerges as the first largest importing country, achieving a total trade value of $2.4M through 0 shipments. This represents a market share of 25.7% of the total market activity, demonstrating their significant presence in the industry.

Key Insight: Russia demonstrates strong market positioning with an average shipment value of $2.4M, indicating premium pricing strategy compared to the market average of $30.1K.

Russia is a key market for Cabazitaxel imports, representing 25.7% of total trade value.

Primary Market

Secondary Market

2Italy

Italy emerges as the second largest importing country, achieving a total trade value of $1.4M through 2 shipments. This represents a market share of 14.8% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Italy has a diverse importer base, with their top importers including:

• ACCORD HEALTHCARE ITALIA SRL. - $451.6K (33.0% of country's total business)

Buyer Segment Analysis

TransData Nexus Cabazitaxel buyer market intelligence

1Buyer Segment Analysis

The importation of Cabazitaxel from India involves various buyer segments, each with distinct purchasing behaviors:

Distributors: Entities like ACCORD HEALTHCARE POLSKA SP. Z.O.O. (Poland), ACCORD HEALTHCARE ITALIA SRL. (Italy), and ACCORD HEALTHCARE, SLU (Spain) function as intermediaries, procuring Cabazitaxel in bulk and supplying it to healthcare providers. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.

Hospital Groups: Organizations such as ALLOGA FRANCE (Netherlands) and PHARMADOX HEALTHCARE LTD (Malta) represent hospital networks that import Cabazitaxel directly for patient treatment. Their procurement is driven by patient demand and treatment schedules, leading to consistent, moderate-sized orders.

Re-exporters: Companies like BROCACEF NL HUB (Netherlands) may act as re-exporters, importing Cabazitaxel for redistribution to other markets. Their buying behavior is influenced by international demand fluctuations, resulting in variable order sizes and frequencies.

The repeat buyer rate of 47.7% indicates a substantial proportion of buyers engage in ongoing procurement, reflecting sustained demand and the critical role of Cabazitaxel in oncology treatments.

Country-Specific Import Regulations

TransData Nexus Cabazitaxel buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the importation of Cabazitaxel involves specific regulatory processes:

Russia:
Regulatory Authority: Ministry of Health of the Russian Federation.
Import Registration Process: Requires submission of a registration dossier, including clinical trial data and quality documentation.
Estimated Timeline: Approximately 12-18 months.
Import Tariff/Duty: Typically ranges from 5% to 10% for pharmaceuticals under HS Code 30049049.

Italy:
Regulatory Authority: Italian Medicines Agency (AIFA).
Import Registration Process: Submission of a marketing authorization application, including product quality, safety, and efficacy data.

Demand Drivers & Market Opportunity

TransData Nexus Cabazitaxel buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Cabazitaxel in importing countries is primarily driven by the prevalence of metastatic castration-resistant prostate cancer (mCRPC), for which Cabazitaxel is a standard treatment. Government healthcare programs and the expansion of universal health coverage have increased access to such essential medicines. For instance, the inclusion of Cabazitaxel in national formularies and reimbursement schemes facilitates its availability to patients.

Additionally, the World Health Organization's Essential Medicines List (EML) influences procurement decisions, encouraging countries to prioritize the acquisition of listed medicines like Cabazitaxel. Tender-based purchasing mechanisms are commonly employed, allowing governments and healthcare institutions to procure Cabazitaxel at competitive prices, ensuring a steady supply to meet patient needs. The presence of 107 buyers across 49 countries underscores the global reliance on Cabazitaxel for effective cancer treatment.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Cabazitaxel Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest cabazitaxel buyer importing from India?

Based on import volume and value, ACCORD HEALTHCARE POLSKA SP. Z.O.O. (POLAND) leads with $573.9K in imports and a 6.2% market share — the highest of any single cabazitaxel importer. ACCORD HEALTHCARE ITALIA SRL. (ITALY) and MSN LABS CHILE SPA (CHILE) are the next largest buyers.

QHow many companies buy cabazitaxel from India?

There are 107 active cabazitaxel buyers importing from India, with a combined market of $9.2M across 307 shipments to 49 countries. The top 5 buyers hold 23.9% of total import value, while the remaining 102 buyers handle the other 76.1%.

QWhich countries import the most cabazitaxel from India?

The top importing countries for cabazitaxel from India are Russia (25.7%), Italy (14.8%), Netherlands (12.9%), Poland (11.4%), Malta (8.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of cabazitaxel, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for cabazitaxel from India?

The average import transaction value for cabazitaxel from India is $30.1K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Cabazitaxel buyer market intelligence

1Buyer Segment Analysis

The importation of Cabazitaxel from India involves various buyer segments, each with distinct purchasing behaviors:

Distributors: Entities like ACCORD HEALTHCARE POLSKA SP. Z.O.O. (Poland), ACCORD HEALTHCARE ITALIA SRL. (Italy), and ACCORD HEALTHCARE, SLU (Spain) function as intermediaries, procuring Cabazitaxel in bulk and supplying it to healthcare providers. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.

Hospital Groups: Organizations such as ALLOGA FRANCE (Netherlands) and PHARMADOX HEALTHCARE LTD (Malta) represent hospital networks that import Cabazitaxel directly for patient treatment. Their procurement is driven by patient demand and treatment schedules, leading to consistent, moderate-sized orders.

Re-exporters: Companies like BROCACEF NL HUB (Netherlands) may act as re-exporters, importing Cabazitaxel for redistribution to other markets. Their buying behavior is influenced by international demand fluctuations, resulting in variable order sizes and frequencies.

The repeat buyer rate of 47.7% indicates a substantial proportion of buyers engage in ongoing procurement, reflecting sustained demand and the critical role of Cabazitaxel in oncology treatments.

Country-Specific Import Regulations

TransData Nexus Cabazitaxel buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the importation of Cabazitaxel involves specific regulatory processes:

Russia:
Regulatory Authority: Ministry of Health of the Russian Federation.
Import Registration Process: Requires submission of a registration dossier, including clinical trial data and quality documentation.
Estimated Timeline: Approximately 12-18 months.
Import Tariff/Duty: Typically ranges from 5% to 10% for pharmaceuticals under HS Code 30049049.

Italy:
Regulatory Authority: Italian Medicines Agency (AIFA).
Import Registration Process: Submission of a marketing authorization application, including product quality, safety, and efficacy data.

Demand Drivers & Market Opportunity

TransData Nexus Cabazitaxel buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Cabazitaxel

Cabazitaxel

Who Buys Cabazitaxel from India — 107 Importers Behind a $9.2M Market

Top Cabazitaxel Importers — Ranked by Import Value

Top Cabazitaxel Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Cabazitaxel — and from which countries?

Cabazitaxel — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Russia

2Italy

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Cabazitaxel Buyers & Importers

QWho is the largest cabazitaxel buyer importing from India?

QHow many companies buy cabazitaxel from India?

QWhich countries import the most cabazitaxel from India?

QWhat is the average import order value for cabazitaxel from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Netherlands

4Poland

5Malta

Analysis Methodology